Additionally, we substantiated our findings in multiple cell lines, human cancer cell xenograft models, and genetically engineered mouse models, wherein the loss of ZNRF3/RNF43 resulted in elevated EGFR levels and facilitated cancer progression. The gene discussed is ZNRF3; the disease is cancer.